Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy

Motoo Nomura, Taisuke Hosokai, Masashi Tamaoki, Akira Yokoyama, Shigemi Matsumoto, Manabu Muto